ID
34470
Description
Effectiveness of Conversion to Sirolimus Versus Calcineurin Inhibitor (CNI) Reduction in Renal Transplant Patients With Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00922129
Link
https://clinicaltrials.gov/show/NCT00922129
Keywords
Versions (3)
- 1/17/19 1/17/19 -
- 5/27/19 5/27/19 -
- 5/29/19 5/29/19 -
Copyright Holder
see on clinicaltrials.gov
Uploaded on
January 17, 2019
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Prostate Cancer NCT00922129
Eligibility Prostate Cancer NCT00922129
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
ID.4
Data type
boolean
Description
ID.5
Data type
boolean
Description
ID.6
Data type
boolean
Description
ID.7
Data type
boolean
Description
ID.8
Data type
boolean
Description
ID.9
Data type
boolean
Description
ID.10
Data type
boolean
Similar models
Eligibility Prostate Cancer NCT00922129
- StudyEvent: Eligibility